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Abstract
Background: The production of virulence factors in Staphylococcus aureus is tightly controlled by a complex web
of interacting regulators. EsxA is one of the virulence factors that are excreted by the specialized, type VII-like Ess
secretion system of S. aureus. The esxA gene is part of the s
B-dependent SpoVG subregulon. However, the mode
of action of SpoVG and its impact on other global regulators acting on esxA transcription is as yet unknown.
Results: We demonstrate that the transcription of esxA is controlled by a regulatory cascade involving downstream
s
B-dependent regulatory elements, including the staphylococcal accessory regulator SarA, the ArlRS two-
component system and SpoVG. The esxA gene, preceding the ess gene cluster, was shown to form a
monocistronic transcript that is driven by a s
A promoter, whereas a putative s
B promoter identified upstream of
the s
A promoter was shown to be inactive. Transcription of esxA was strongly upregulated upon either sarA or sigB
inactivation, but decreased in agr, arlR and spoVG single mutants, suggesting that agr, ArlR and SpoVG are able to
increase esxA transcription and relieve the repressing effect of the s
B-controlled SarA on esxA.
Conclusion: SpoVG is a s
B-dependent element that fine-tunes the expression of esxA by counteracting the s
B-
induced repressing activity of the transcriptional regulator SarA and activates esxA transcription.
Background
The production of virulence factors in Staphylococcus
aureus is coordinated by a network of two-component
systems, global regulators and transcription factors,
allowing optimal adaptation of the pathogen to a chan-
ging environment and stress conditions encountered
during the various stages of infection. A central regula-
tory element of virulence factor production in S. aureus
is the accessory gene regulator agr, a two-component
quorum sensor regulating gene expression in a growth-
dependent manner. The main effector molecule of the
agr operon is the regulatory RNAIII [1], which is
responsible essentially for the upregulation of secreted
proteins in the post-exponential phase. RNAIII tran-
scription is enhanced by the staphylococcal accessory
regulator SarA [2] and reduced by the alternative sigma
factor s
B in strain Newman [3,4]. SarA is a winged helix
transcription factor influencing many virulence genes
[5,6]. The transcription of sarA in turn is directly acti-
vated by the alternative sigma factor s
B [3], which con-
trols over 250 genes including virulence factors and
secondary regulators in a direct or indirect way [7].
Indirectly s
B-controlled genes lack a s
B consensus pro-
moter sequence, and are thought to be controlled by
secondary, s
B-dependent regulatory elements. The yabJ-
spoVG operon, with SpoVG as effector molecule, is
besides SarA one of the directly s
B -dependent second-
ary regulators [8]. SpoVG contributes to methicillin and
glycopeptide resistance, stimulates capsule synthesis, and
was recently shown to regulate a small s
B-subregulon
comprising mainly excreted virulence factors including
the highly upregulated virulence factor EsxA [8-10].
Secretion of virulence factors is facilitated by several
translocation systems in S. aureus [11], the major Sec
pathway, the accessory Sec2 system [12], the twin-argi-
nine translocation pathway [13], and the type VII-like
specialized ESX secretion pathway (Ess) [14]. The Ess
system comprises a cluster of at least nine genes: esxAB,
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with a size of approximately 100 amino acids containing
a helical structure and a conserved Trp-Xaa-Gly (WXG)
motif [16]. Three proteins were so far shown to be
exported by the staphylococcal Ess system, two
WXG100 family proteins, EsxA and EsxB, and the non-
WXG100 substrate EsaC [14,17]. All three proteins act
as pathogenicity factors in a murine model of staphylo-
coccal blood-borne dissemination and abscess formation
[14,17]. The actual role of EsxA, EsxB and EsaC remains
unclear. Structural analysis of EsxA suggests a role as
transport module or chaperone to assist export of pro-
teins by the Ess secretion pathway rather than being an
effector protein itself [18]. The esxA gene seems to be
under complex control. Besides being upregulated by
SpoVG [10], esxA was found to be upregulated by ArlR
[19]. The two-component system ArlRS [19,20] itself is
activated in an indirect way by s
B in strain Newman
[3,9], adding a further level of complexity in the regula-
tion of esxA.
This study analyses the transcriptional control of esxA
by s
B and the s
B-dependent regulatory elements SarA,
ArlR, RNAIII and SpoVG.
Materials and methods
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids are listed in Table 1.
Bacteria were grown on Luria Bertani (LB) agar (Becton
Dickinson, Franklin Lakes, NJ, USA) or in LB broth
with shaking (180 rpm) at 37°C in a flask to medium
ratio 5:1. Where required, media were supplemented
with 100 μgm l
-1 ampicillin, 20 μgm l
-1 chlorampheni-
col, 10 μgm l
-1 erythromycin, or 10 μgm l
-1 tetracycline.
Molecular biological methods
General molecular biology techniques were performed
according to standard protocols [32,33]. Sequencing was
done using the Big Dye Terminator Cycle Sequencing
Ready Reaction Kit and an ABI Prism 310 genetic analy-
zer (Applied Biosystems, Foster City, CA, USA).
Sequences were analyzed with the Lasergene software
package (DNASTAR, Inc., Madison, WI, USA).
Construction of ΔesxA mutants
The markerless deletion of esxA (nwmn_0219) in strains
Newman, BB1002 and NM143 was constructed using
the counter selection system of pKOR1 as described by
Bae et al. [28], using primer pairs oBS43/oBS44 and
oBS45/oBS46 (Table 2) to amplify sequences framing
esxA. Correct deletion of esxA in BS304, BS307 and
BS308, respectively, was confirmed by sequencing and
Southern blot analysis, and the absence of major rear-
rangements by pulsed-field gel electrophoresis [34].
Construction of BS309 and BS310
The Newman sarA mutant BS309 and the Newman agr
mutant BS310 were constructed by transducing the
ermB-tagged sarA mutation of NM520 [38], and the
ermB-tagged agr mutation of NM521 [38] respectively,
into Newman and selecting for erythromycin resistance.
Correct inactivation of the genes was confirmed by
sequencing and Southern blot analysis.
Plasmid construction
For the construction of promoter-lacZ reporter fusions,
DNA fragments covering the yabJ or esxA promoter of
strain Newman were amplified using primer pairs yab-
prom-bam-f/yab-prom-xho-r and Pnwmn0219F/
Pnwmn0219R-xho (Table 2), respectively. The PCR pro-
ducts were digested with BamHI and XhoI and ligated
into promoter probe plasmid pSB40N [29] upstream of
the lacZa reporter gene to obtain pyabJp and pesxAp.
For the construction of pesxAp-luc
+ ,t h eesxA promo-
ter region of strain Newman was amplified by PCR
using primer pair Pnwmn0219F-hind/Pnwmn0219R
(Table 1). The resulting PCR product was HindIII/NcoI-
digested and cloned into pSP-luc
+ upstream of the luci-
ferase reporter gene luc
+ .T h eesxA promoter-luc
+
fusion of the resulting plasmid was amplified using the
primers Pnwnm0219F-hind/pSP-Luc XhoI, digested with
HindIII and XhoI and cloned into the E. coli-S. aureus
shuttle plasmid pBus1 to obtain plasmid pesxA-luc
+ .
Plasmids pesxApΔs
A-luc
+ and pesxApΔs
B-luc
+ were
made by deleting the s
A and s
B promoter sequences,
respectively, from pesxAp-luc
+ . The corresponding
DNA fragments were amplified with primer pairs
oBS49/oBS53 and oBS51/oBS54 (Table 2) from pesxAp-
luc
+ and religated.
All plasmids constructs were confirmed by sequence
analyses.
Northern blot analysis
Overnight cultures were diluted 1:100 into LB, grown for
2 h, and then used to inoculate 100 ml of pre-warmed
LB to an optical density of 600 nm [OD600 nm] of 0.05.
Cell samples were taken at the time points indicated, cen-
trifuged at 12,000 × g and 4°C for 2 min, the pellets were
snap-frozen in liquid nitrogen. Total RNA was isolated
according to Cheung et al. [39]. RNA samples (8 μg)
were separated in a 1.5% agarose gel containing 20 mM
guanidine thiocyanate in 1 × Tris-borate-EDTA buffer
[40]. RNA transfer and detection were performed as pre-
viously described [41,42]. Digoxigenin (DIG) labelled
probes were amplified using the PCR DIG Probe synth-
esis kit (Roche, Basel, Switzerland). The primer pairs
used for amplification of the esxA, spoVG, asp23, arlR,
sarA and RNAIII probes are listed in Table 2.
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RNA was extracted from LR15 cultures that were grown to
OD600 nm 2.0, as described by Cheung et al. [39]. Primer
extension reactions were performed using 20 μgo ft o t a l
R N Aa n d3p m o lo ft h e5 ’-biotin-labelled primers
pe_esxA_1 and pe_esxA_2 (Table 2) using Superscript II
reverse transcriptase (Invitrogen, Carlsbad, CA, USA),
according to the manufacturers instructions. Sequencing
reactions were performed using the Thermo Sequenase
Cycle Sequencing Kit (USB Corporation, Cleveland,
OH, USA) and template DNA amplified with primers
Pnmmn0219F and esxA_term-r from Newman genomic
DNA. The Biotin Chromogenic Detection Kit (Fermentas,
Burlington, Ontario, Canada) was used for biotin detection.
Table 1 Strains and plasmids used in this study
Strain or
plasmid
Relevant genotype; phenotype Reference or
source
S. aureus
Newman Clinical isolate, ATCC 25904, natural saeS constitutive mutant [21,22]
BS304 Newman ΔesxA, markerless deletion This study
SM148 Newman Δ(yabJ-spoVG)::erm(B); Em
r [8]
IK184 Newman Δ(rsbUVW-sigB)::erm(B); Em
r [23]
MS64 Newman sigB1(Am); Tc
r [24]
SM99 Newman ΔarlR::cat;C m
r [9]
BS310 Newman Δagr::ermB;E m
r This study
KS186 Newman Δagr::tet(M);T c
r [25]
BS309 Newman ΔsarA::ermB;E m
r This study
LR15 Newman ΔsarA::tet(L);T c
r L. Reutimann
BB1002 Newman mec, MRSA derivative, Mc
r [26]
BS307 BB1002 ΔesxA, markerless deletion This study
NM143 Newman GISA derivative, in vitro selected mutant; Te
r [27]
BS308 NM143 ΔesxA, markerless deletion This study
E. coli
DH5a F
-F80d/acZΔM15 recA1 Invitrogen
Plasmids
pKOR1 E. coli-S. aureus shuttle vector for markerless deletions using the counter selection system [28]
pAC7 Expression plasmid containing the PBAD promoter and the araC gene; Cm
r [29]
pAC7-sigB pAC7 with a 0.75 kb fragment containing the gene sigB from S. aureus Col; Cm
r [30]
pBus1 E. coli-S. aureus shuttle plasmid with multicloning site from pBluescript II SK (Stratagene) and the rrnT14
terminator sequence from pLL2443; Tc
r
[31]
pyabJ pBus1 containing a bacA promoter-yabJ ORF fusion construct; Tc
r [10]
pspoVG pBus1 containing a bacA promoter-spoVG ORF fusion construct; Tc
r [10]
pyabJspoVG pBus1 containing a bacA promoter-yabJ-spoVG operon fusion construct; Tc
r [10]
pSP-luc
+ Firefly luciferase casette vector; Ap
r Promega
pesxAp-luc
+ pBus1 containing an esxAp-luc
+ fusion fragment; Tc
r This study
pesxApΔs
A-luc
+
pesxAp-luc
+ with deletion of the s
A promoter This study
pesxApΔs
B-luc
+
pesxAp-luc
+ with deletion of the s
B promoter This study
pSB40N Promoter probe plasmid; Ap
r [29]
pasp23p pSB40N with a 0.6 kb fragment covering the asp23 promoter region fused to the reporter gene lacZa;A p
r [30]
pesxAp pSB40N with a 0.5 kb fragment covering the esxA promoter region fused to the reporter gene lacZa;A p
r This study
pyabJp pSB40N with a 0.4 kb fragment covering the yabJ promoter region fused to the reporter gene lacZa;A p
r This study
pSTM07 pSB40N with a 0.37 kb fragment covering the capA promoter region fused to the reporter gene lacZa;A p
r [9]
a Abbreviations are as follows: Ap
r, ampicillin resistant; Cm
r, chloramphenicol resistant; Em
r, erythromycin resistant; Mc
r, methicillin resistant; Tc
r, tetracycline
resistant; Te
r, teicoplanin resistant.
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Testing of the interaction of S. aureus promoters with E.
coli RNA polymerase containing S. aureus s
B was done
essentially as described earlier [30]. The promoter-reporter
plasmids pasp23p (asp23 promoter); pyabJp (yabJ promo-
ter); pesxap (esxA promoter); and pSTM07 (capA promo-
ter); or the empty plasmid pSB40N, were transformed into
E. coli DH5a containing either pAC7-sigB or pAC7. The
color production of the clones was analyzed on LBACX-
ARA plates (LB agar containing 5 mg ml
-1 lactose; 100 μg
ml
-1 ampicillin; 40 μgm l
-1 chloramphenicol; 20 μgm l
-1 X-
Gal (5-bromo-4-chloro3-indolyl-D-galactopyranoside) and
2 μgm l
-1 arabinose) [29].
Luciferase assay
Luciferase activity was measured as described earlier [3]
using the luciferase assay substrate and a Turner
Designs TD-20/20 luminometer (Promega).
Table 2 Oligonucleotide primers used in this study
Primer name Sequence (5’-3’)
a reference
esxA deletion
oBS43 GGGGACAAGTTTTGTACAAAAAAGCAGGCTacgtttatcaaagacatacc This study
oBS44 gggggtaccaactagaaacctcctgaata This study
oBS45 gggggtaccgcattctgaaattggcaaag This study
oBS46 GGGGACCACTTTGTACAAGAAAGCTGGGTttatccatcgctgtattgtg This study
DIG probes
Nwmn0219-DIG-f tccagaggaaatcagagcaaa [10]
Nwmn0219-DIG-r cttgttcttgaacggcatca [10]
oSTM29 (spoVGf) gcgtcgacttattgcaaatgtattacatcgc [9]
oSTM43 (spoVGr) gcggagctccactcgtttccattacattagatg [8]
SasarAf agggaggttttaaacatggc [35]
SasarAf ctcgactcaataatgattcg [35]
RNAIII+ gtgatggaaaatagttgatgag [3]
RNAIII- gtgaatttgttcactgtgtcg [3]
arlRSprobe+ tcgtatcacatacccaacgc [36]
arlRSprobe- gagtatgatggacaagacgg [36]
SAasp23+ atgactgtagataacaataaagc [37]
SAasp23- ttgtaaaccttgtctttcttgg [37]
plasmid construction
Pnwmn0219F tgcggatccgatcacgttgatttgcgtgt This study
Pnwmn0219R-xho tgcctcgagctagaaacctcctgaatattttaag This study
yab-prom-bam-f gcgggatcctgctaatattttaaatttacc This study
yab-prom-xho-r gcgctcgagtactaaaactccttttatgaaaac This study
Pnwmn0219F-hind tgcaagcttgatcacgttgatttgcgtgt This study
Pnwmn0219R tgcccatggctagaaacctcctgaatattttaag This study
pSP-Luc XhoI accggcctcgagatcgatgatatcgaa This study
oBS49 tagttttttaagtatttttagtttttttta This study
oBS51 attcaatatatttatttaaaaaaaactaaaaa This study
oBS53 aggtaccttgagtaaggagcactttttcaa This study
oBS54 aggtaccattcatttttgtaatataaatgtgtatac This study
primer extension This study
pe_esxA_1 BIOTIN-ccataactagaaacctcctg This study
pe_esxA_2 BIOTIN-tgatttcctctggactcatc This study
esxA_term-r tgcggtaccatgcttatttcctttcagttg This study
a Restriction sites are underlined. Capital letters show the att sites.
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The proteolytic activity of S. aureus strains was deter-
mined on skim milk (Becton Dickinson, 75 g l
-1)a g a r
plates as clear zones surrounding colonies.
Hemolytic activity
To compare the hemolytic activity, S. aureus strains
were grown on sheep blood agar and the clear halos
around the colonies were analyzed.
Susceptibility testing
Plates containing an antibiotic gradient were prepared
a n di n o c u l a t e db ys w a b b i n ga0 . 5M c F a r l a n dc e l ls u s -
pension in physiological NaCl solution along the gradi-
ent as described before [27]. Growth was read after 24 h
and 48 h of incubation at 35°C. Teicoplanin and oxacil-
lin minimal inhibitory concentrations (MICs) were
determined using Etests according to the manufacturer’s
instructions (AB-Biodisk, Solna, Sweden).
Results and discussion
Transcriptional analysis of esxA
The 294 bp esxA gene (nwmn_0219, GenBank accession
no. NC_009641), coding for a small secreted protein
involved in staphylococcal virulence, is the first of at
least nine genes of the ess gene cluster encoding the
type VII-like ESX-1 secretion pathway (Ess) in S. aureus
(Figure 1A) [14,15]. Although esxA seems to belong
transcriptionally to the ess gene cluster [43], transcrip-
tional profiling produced one single esxA-specific tran-
script with a size of about 0.45 kb appearing in early
growth phase after 1 h and increasing slightly within
time (Figure 1B). No esxA-specific signals were detected
in the corresponding ΔesxA mutant BS304, confirming
the esxA deletion. The deletion of esxA had no polar
effects on the expression of the downstream ess genes,
nor on the divergently transcribed gene directly
upstream of esxA, predicted to be involved in staphylox-
anthin synthesis [37,44,45] (data not shown). Our results
aaggagcactttttcaaaaaatagtgtccctaaaaagttttgataaacttaaaatattcaggaggtttctagttatg
esxA
0 2.5 5.0 7.5 10.0 12.5
[kb]
16S
1358
Newman
1358
'esxA
[h]
B
A
C
C
T
RT
G
A
15.0
PVA
TSP RBS START
0.45 kb
Figure 1 esxA in S. aureus. A. Schematic representation of the ess locus of S. aureus Newman (GenBank accession no. NC_009641). ORF
notations correspond to those used by Anderson et al. [15]. The s
A promoter, transcriptional start point (TSP) and ribosomal binding site (RBS)
as well as the start codon of esxA are indicated. B. Northern blot of esxA of strain Newman and the isogenic ΔesxA mutant (BS304) during
growth. The ethidium bromide-stained 16S rRNA pattern is shown as an indication of RNA loading. C. Primer extension analysis of esxA. Lanes C,
T, A and G show the dideoxy-terminator sequencing ladder and lane RT the reverse transcription product obtained using primer pe_esxA_2. The
TSP is marked by an arrow. The same TSP was identified using primer pe_esxA_1 (data not shown).
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script and is not co-transcribed with the remaining
genes of the ess gene cluster.
esxA promoter and terminator sequence analysis
In a microarray of strain Newman, esxA transcription was
found to be upregulated by the s
B-controlled yabJ-spoVG
operon [10]. Searching the nucleotide sequence upstream
of the esxA ORF for potential s
A (TTGACA-16/18-
TATAAT) [46,47] and s
B (GTTTAA-12/15-GGGTAT)
[30] consensus promoter sequences and for a ribosomal
binding site (AGGAGG) [48], we identified 80 bp
upstream of esxA ap u t a t i v es
A promoter (TatACA-17-
TATtAT), and 155 bp upstream of esxA a potential s
B
promoter (GgTTAA-12-GGGTAT). A proposed riboso-
mal binding site (RBS, AGGAGG) was located 9 bp
upstream of the esxA start codon (Figure 1A). Fourteen bp
downstream of the esxA stop codon we identified a puta-
tive Rho independent terminator consisting of a 13 bp
inverted repeat with a minimal free energy ΔGo f- 1 7k c a l /
mol as calculated by mfold [49].
Primer extension analysis located the transcriptional
start point (TSP) of esxA 74 bp upstream of the start
codon of esxA (Figure 1A-C). It was preceded by the
predicted -10 and -35 s
A promoter elements, and
further up by the s
B promoter.
To verify and compare the function of the putative s
A
and s
B promoter sequences, we cloned the esxA promo-
ter region upstream of the firefly luciferase reporter
gene and analyzed the luciferase activity of this con-
struct, pesxAp-luc
+,a sw e l la so fc o n s t r u c t sc o n t a i n i n g
either a deletion of the s
A or s
B promoter (pesxApΔs
A-
luc
+,p esxApΔs
B-luc
+). Whereas the relative luciferase
activities of pesxAp-luc
+ and pesxApΔs
B-luc
+ after 3 h
of growth were comparable, pesxApΔs
A-luc
+ showed
almost no activity, suggesting that esxA possesses a s
A-
dependent promoter (Figure 2). We could rule out a
direct involvement of s
B in the control of the esxA pro-
moter, furthermore, by testing the esxA upstream region
in the heterologous two-plasmid system that was estab-
lished to identify s
B-dependent S. aureus promoters
[30]. The upstream region of esxA was cloned into the
reporter plasmid pSB40N resulting in plasmid pesxAp
which then was introduced into E. coli DH5a containing
either pAC7-sigB,e x p r e s s i n gt h eS. aureus sigB gene
from an inducible promoter, or the empty plasmid
pAC7. If the S. aureus s
B - E. coli RNA polymerase core
enzyme hybrid recognized the esxA promoter, dark blue
colonies would be expected on the indicator LBACX-
ARA agar [29] in combination with pAC7-sigB,a sw i t h
the s
B-dependent promoters of asp23 or yabJ (positive
controls); if not, uncolored colonies would be expected,
as with the s
B-independent promoter of capA or the
empty pSB40N (negative controls). In contrast,
transformants containing the empty pAC7 vector should
produce uncolored colonies. However, both combina-
tions, pesxAp with either pAC7 or pAC7-sigB, developed
an identical only light blue color in E. coli DH5a,i n d i -
cating that the esxA promoter was recognized weakly by
an E. coli RNA polymerase, but that the observed tran-
scriptional activity was independent from s
B (data not
s h o w n ) .O v e r a l l ,t h er e s u l t so ft h eesxA promoter and
terminator sequence analyses supported a monocistronic
transcription of esxA from a s
A-dependent promoter.
Effect of s
B and s
B-controlled SpoVG on esxA expression
To differentiate between the effect of s
B and of the s
B-
controlled yabJ-spoVG on the transcriptional control of
esxA, we followed the luciferase activity of the esxA pro-
moter-reporter fusion in pesxAp-luc
+ during the growth
cycle in parental strain Newman, the corresponding
ΔrsbUVW-sigB mutant (IK184), and in the ΔyabJ-spoVG
mutant (SM148). The luciferase activity increased in the
parent Newman in a growth phase dependent manner
from the exponential towards the stationary phase and
declined thereafter (Figure 3A). The course of luciferase
activity in the ΔyabJ-spoVG mutant SM148 and in the
ΔrsbUVW-sigB mutant IK184 was comparable but the
overall activity was reduced by a factor of two in
SM148, whereas it was two up to four times higher in
IK184. These effects were also mirrored by the intensity
of the esxA specific transcripts (Figure 3B). Since esxA
transcription in strain MS64 [24], a mutant with a stop
in sigB inactivating s
B, was indistinguishable from that
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Figure 2 s
A-dependence of the esxA promoter.L u c i f e r a s e
activities of plasmids pesxAp-luc
+ (wt), pesxApΔs
A-luc
+ (Δs
A) and
pesxApΔs
B-luc
+ (Δs
B)i nS. aureus Newman. The strains were grown
in LB broth at 37°C and 180 rpm for 3 h. Data shown are the
means ± SD of four independent experiments. Statistical
significances between the different strains were assessed with a
paired, two-tailed Student’s t-test (* p < 0.01).
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scription to the loss of s
B and exclude any contributions
of rsbUVW (data not shown).
To determine if either yabJ or spoVG inactivation was
responsible for the reduction of esxA transcription, we
complemented Newman, SM148 and IK184 in trans
with a series of plasmids expressing constitutively either
yabJ (pyabJ), spoVG (pspoVG), or yabJ-spoVG
(pyabJspoVG), circumventing the requirement of s
B to
transcribe the yabJ-spoVG operon. Northern blot analy-
sis revealed that the constructs containing spoVG or
yabJ-spoVG, but not the one carrying yabJ,d i dr e s t o r e
the esxA transcription to wild type level in SM148 (Fig-
ure 3C). In IK184, showing stronger esxA transcription
signals than the wild type, the esxA transcription was
even further enhanced by the complementation with
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Figure 3 Effect of s
B and s
B-controlled SpoVG on esxA expression. A. Transcriptional activity of the esxA promoter in strain Newman
(squares), SM148 (triangles), and IK184 (diamonds). Growth was followed by measuring the optical density at 600 nm [OD600] (open signs), and
the activity of the esxA promoter was determined by the luciferase activity of pesxAp-luc
+ (filled signs). B. Northern blot analysis of esxA
transcription in Newman, the ΔyabJ-spoVG mutant (SM148) and the ΔrsbUVW-sigB mutant (IK184) over growth. C. Northern blot showing esxA
transcription in Newman, the ΔyabJ-spoVG mutant (SM148) and the ΔrsbUVW-sigB mutant (IK184) complemented with pBus1, pyabJ,p spoVG or
pyabJspoVG after 5 h of growth. Ethidium bromide-stained 16S rRNA patterns are shown as an indication of RNA loading.
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Page 7 of 11pspoVG or pyabJspoVG, confirming that SpoVG, but not
YabJ, had a positive effect on esxA expression in pre-
sence and absence of s
B. However, the fact that esxA
transcription was strongly induced in IK184 lacking not
only s
B, but consequently also the s
B-dependent
SpoVG, suggested that esxA transcription may be acti-
vated by SpoVG but repressed by other s
B-dependent
factors.
Influence of major regulators SarA, RNAIII and ArlR on
esxA
As s
B and SpoVG had opposite effects on esxA expres-
sion, we searched for further s
B-dependent regulators
that might be involved in esxA control, namely the two
major regulators of S. aureus,t h eagr system with its
effector molecule RNAIII; and the transcriptional regu-
lator SarA. A further candidate was ArlR, the response
regulator of the ArlRS two-component system, reported
to be activated by s
B in strain Newman, and promoting
together with SpoVG capsule formation [9]. The tran-
script intensity of esxA in Newman compared to that in
its isogenic ΔsarA (LR15), Δagr (KS186) and ΔarlR
(SM99) mutants during growth, revealed a strong
upregulation of esxA in LR15, a downregulation in
KS186 and an even stronger attenuation in SM99 (Fig-
ure 4A), suggesting that SarA acts as repressor, and
RNAIII and ArlR as activators of esxA transcription.
This was confirmed by the level of luciferase activity of
pesxAp-luc
+ during growth, which was highly increased
in the ΔsarA mutant (BS309), and lower in the Δagr
(BS310) and almost absent in ΔarlR (SM99) mutants
compared to the wild type Newman (Figure 4B). Inter-
estingly, as in capsule synthesis, SpoVG and ArlR acted
as elements enhancing the esxA expression [9].
Influence of EsxA on regulatory elements and itself
EsxA itself had no influence on the signal intensity or
activity of any of the above regulatory genes, neither on
asp23, as an indicator of s
B activity [37,44,50], nor on
spoVG, arlR, sarA or RNAIII, when comparing their
expression in strain Newman and in the ΔesxA mutant
BS304 during the growth cycle (Additional file 1). We
could also rule out any autoregulatory effects of EsxA
on its own transcription, since luciferase activity pat-
terns of pesxAp-luc
+ were congruent over the entire
growth cycle in Newman and BS304 (data not shown).
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Figure 4 Effect of SarA, agr and ArlR on esxA expression. A. Northern blot of esxA in Newman, and the ΔsarA (LR15), Δagr (KS186) and ΔarlR
(SM99) mutants over growth. The ethidium bromide-stained 16S rRNA pattern is shown as an indication of RNA loading. B. Transcriptional
activity of the esxA promoter in strain Newman (squares), ΔsarA mutant BS309 (stars/dots), Δagr mutant BS310 (triangles), and ΔarlR mutant SM99
(diamonds). Growth was followed by measuring the OD600 (open signs), and the activity of the esxA promoter-reporter construct was
determined by the luciferase activity of pesxAp-luc
+ (filled signs). The strains BS309 and BS310 are isogenic to LR15 and KS186, respectively,
except for an exchanged resistance marker in the inactivated loci allowing the selection and maintenance of pesxAp-luc
+ .
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B, ArlR and SpoVG
on each other
An overview of the regulatory network influencing esxA
transcription is given in Figure 5, including also the
mutual interactions of the different regulators: s
B activ-
i t yw a sf o u n dt ob ec o m p a r a b l ei na l ls t r a i n st e s t e d ,
excluding secondary effects on esxA transcription due to
an altered s
B activity (Additional file 2). We confirmed
the previously reported positive influence of s
B on arlRS
and yabJspoVG transcription [7,9], as well as on sarA
transcription [3,7]. In contrast, we could not detect any
major changes in RNAIII transcript intensity in s
B
mutants, although some studies suggest that s
B activity
is reducing the RNAIII level [3,4] (Additional file 2).
Further, minor changes in transcription were observed
in the ΔsarA mutant where RNAIII was downregulated
and arlR transcripts were slightly upregulated, and in
the ΔarlR mutant where sarA transcription was
increased (Additional file 2: Figure S2A). However, these
dependencies could not explain the changes in esxA
transcription in the corresponding mutants.
Phenotypic characteristics of the ΔesxA mutant
The successful deletion of esxA reported here, and the
superimposable growth rates of wild type and esxA
mutant in complex LB medium, confirmed that EsxA
was not essential for growth in vitro (data not shown).
The growth defects observed in sigB and arlR mutants,
the former affecting late [37] and the latter reducing
early growth stages [19], can therefore also not depend
on altered EsxA expression. Although s
B and SpoVG
are known to influence extracellular proteolytic activities
[9], and s
B is known to repress hemolytic activity in S.
aureus [4,7,37], EsxA did neither affect proteolytic nor
hemolytic activities in BS304 (data not shown). As the
activity of the sigma factor s
B and the s
B-controlled
SpoVG positively influences methicillin and glycopeptide
resistance in methicillin resistant S. aureus (MRSA) and
in glycopeptide intermediate resistant S. aureus (GISA)
[8,51-55], we deleted esxA in MRSA strain BB1002 [26]
and GISA strain NM143 [27]. However, resistance levels
of the ΔesxA mutants BS307 and BS308 to oxacillin and
teicoplanin, respectively, were identical to those of the
parent strains, when measured by Etest (Table 3), as
well as by antibiotic gradient plates, which allow the
detection of very small differences in resistance (data
not shown). These results suggest that EsxA, which
enhances abscess formation in mice and is thought to
act either as transport chaperone or adaptor protein
[18], primarily plays a role as extracellular virulence fac-
tor in pathogenesis.
Conclusion
Our data suggest that the repression of esxA by s
B is
due the s
B-induced transcription of sarA,l e a d i n gt oa
strong and dominating SarA-mediated repression of
esxA. The activation of esxA transcription, on the other
hand, is stimulated by the agr quorum sensing system,
SarA SpoVG ArlR
ıB
RNAIII
Environmental
and host factors
agr quorum
sensing system
esxA
virulence
esxA
virulence
Figure 5 Transcriptional regulation of esxA by global regulators of virulence in strain Newman. Major upregulation is represented by
green arrows, downregulation by red bars. Dashed lines indicate minor influences.
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Page 9 of 11the response regulator ArlR, and the effector protein
SpoVG; whereby arlR is controlled indirectly, and
spoVG directly by s
B. Thereby the activating effect of
ArlR seems to be more profound than the effect of
SpoVG and agr. Moreover, virulence gene regulation in
S. aureus is very complex and additional factors might
contribute to the regulation of esxA transcription.
The mode of function of SpoVG, named after the stage
V sporulation protein G in Bacillus subtilis [7], and
SpoVG homologues in other bacterial species is yet
unknown, nor have any SpoVG interacting partners been
reported. SpoVG does not affect s
B activity as seen from
the expression of asp23, which is a measure of s
B activity
in S. aureus. SpoVG does also not interfere with the tran-
scription of sarA, arlRS nor agr in strain Newman.
By which mechanisms SpoVG counteracts the postu-
lated SarA-mediated repression of esxA remains open.
The affinity of SarA binding to DNA can be enhanced by
phosphorylation [56], but a postulated interaction of
SpoVG with SarA or other proteins has yet to be investi-
gated. Interestingly, the same stimulating effect by ArlRS
and SpoVG is seen in S. aureus capsule synthesis [9]. We
therefore can not rule out that SpoVG and ArlR may
interact or have some common target. SpoVG by itself
seems also to enhance transcription of esxA when artifi-
cially overexpressed in a sigB mutant. The absence of pre-
dicted DNA binding motifs in SpoVG may not fully
exclude its interaction with nucleic acids or with factors
involved in transcription. In conclusion, we have presented
here SpoVG, an interesting new player in the regulatory
cascade modulating S. aureus virulence factors.
Additional material
Additional file 1: No influence of EsxA on asp23, arlR, sarA, spoVG
and RNAIII transcription. Northern blot analysis comparing the
transcript intensities of asp23, arlR, sarA, spoVG and RNAIII in S. aureus
Newman and its ΔesxA mutant.
Additional file 2: Influence of SarA, RNAIII, s
B, ArlR and SpoVG on
each other. Northern blot analysis comparing the transcript intensities of
asp23, arlR, sarA, spoVG and RNAIII in S. aureus Newman, and its isogenic
ΔsarA, Δagr, ΔarlR, ΔyabJspoVG and ΔrsbUVW-sigB mutant, respectively.
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